GlassScriptPhysician profile
Carl Gerardi
NPI 1730104936
$20,381.86
in general payments reported to CMS, 2019-2025
52 companies · $4,149 in 2025
The $4,149 reported for 2025 was more than what 89% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,936 · 2020: $1,012 · 2021: $3,664 · 2022: $3,528 · 2023: $2,547 · 2024: $2,546 · 2025: $4,149.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,106 · Education: $135.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,106.38 |
| Education | $135.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $2,084.32 | 2019-2025 | Xtandi, Myrbetriq, Veozah |
| Boston Scientific Corporation | $2,041.60 | 2019-2025 | Rezum Generator, Ams 700, Xpeeda Dsl Fiber |
| Janssen Biotech, INC. | $1,979.89 | 2019-2025 | Erleada, Akeega, Balversa |
| Teleflex LLC | $1,479.58 | 2021-2025 | Urolift, Barrigel |
| Urogen Pharma, INC. | $1,328.87 | 2021-2025 | |
| Sumitomo Pharma America, INC. | $1,328.63 | 2023-2025 | Gemtesa, Orgovyx |
| Neotract INC. | $949.27 | 2019-2020 | |
| Pfizer INC. | $940.19 | 2019-2025 | |
| Coloplast Corp | $931.41 | 2019-2025 | Altis, Porges Coloplast |
| Dendreon Pharmaceuticals LLC | $886.92 | 2019-2025 | Provenge |
| Urovant Sciences INC | $751.18 | 2021-2022 | |
| Progenics Pharmaceuticals, INC. | $670.74 | 2022-2025 | Pylarify |
| Endo Pharmaceuticals INC. | $653.80 | 2019-2024 | Aveed, Xiaflex, Edex |
| Bayer Healthcare Pharmaceuticals INC. | $599.12 | 2019-2025 | |
| Myovant Sciences INC. | $354.90 | 2021-2022 |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $293.36 | 2019-2025 | Adstiladrin |
| Tolmar, INC. | $266.27 | 2023-2025 | Eligard, Jatenzo |
| Abbvie INC. | $256.61 | 2019-2023 | |
| Medtronic, INC. | $249.36 | 2021-2024 | Interstim |
| Kerecis Limited | $222.25 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Calyxo, INC. | $208.57 | 2025 | Cvac Aspiration System |
| Verity Pharmaceuticals INC. | $176.04 | 2024-2025 | Trelstar, Tlando |
| Merck Sharp & Dohme LLC | $159.90 | 2021-2024 | Keytruda, Lynparza |
| Myriad Genetic Laboratories, INC. | $156.64 | 2021-2024 | Prolaris |
| Endo USA, INC. | $147.68 | 2024-2025 | Xiaflex, Aveed, Edex |
| Olympus America INC. | $145.24 | 2024-2025 | Itind System |
| Blue Earth Diagnostics | $133.70 | 2019-2023 | |
| Acerus Pharmaceuticals Corporation | $130.60 | 2021-2022 | |
| Procept Biorobotics Corporation | $71.96 | 2019-2024 | Aquabeam System |
| Sun Pharmaceutical Industries INC. | $66.79 | 2024-2025 | |
| Tolmar Pharmaceuticals, INC. | $65.76 | 2019 | |
| Amgen INC. | $59.70 | 2021-2022 | |
| Dentsply Ih INC. | $59.34 | 2021-2022 | |
| Accord Healthcare, INC. | $58.50 | 2023-2025 | |
| Antares Pharma, INC. | $49.16 | 2021-2025 | Xyosted |
| Clarus Therapeutics INC. | $48.81 | 2021 | |
| Axonics, INC. | $38.79 | 2022-2023 | Bulkamid |
| Astrazeneca Pharmaceuticals LP | $35.06 | 2025 | Imfinzi |
| Immunitybio, INC. | $28.21 | 2025 | |
| Palette Life Sciences, INC. | $27.38 | 2022 | |
| Edap Technomed INC | $27.00 | 2024 | |
| Bioprotect Medical, INC. | $24.98 | 2024 | Bioprotect Balloon Implant System |
| Medtronic USA, INC. | $23.81 | 2019 | |
| Azurity Pharmaceuticals, INC. | $23.77 | 2025 | Azmiro |
| C. R. Bard, INC. & Subsidiaries | $22.51 | 2021 | |
| Genzyme Corporation | $20.75 | 2022 | |
| Janssen Pharmaceuticals, INC | $20.18 | 2021 | |
| Axogen | $18.71 | 2022 | |
| Novartis Pharmaceuticals Corporation | $18.56 | 2019 | |
| Alfasigma USA, INC. | $17.04 | 2021 | |
| 180 Medical, INC. | $16.30 | 2024 | |
| Photocure INC | $12.15 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carl Gerardi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.